Emerging Risks in Synthetic Biology: From Defintions to Recommendations for Science and Policy


Between September 2014 and December 2015 the European Commission’s Scientific Committees (SCENIHR, SCCS, SCHER) and a group of external experts published three Opinions regarding the upcoming challenges to risk assessment... [ view full abstract ]


  1. Markus Schmidt (Biofaction KG)
  2. Michelle M. Epstein (Medical University of Vienna)
  3. Theo Vermeire (RIVM, National Institute for Public Health and the Environment)

Topic Areas

Evidence to inform risk relevant policy , Risk analysis and assessment of natural and technological hazards


T4_A » Health 1 (11:00 - Monday, 20th June, CB3.9)

Presentation Files

The presenter has not uploaded any presentation files.